Find Amphetamine Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

0

EU WC

0

KDMF

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

341RELATED EXCIPIENT COMPANIES

557EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Dl-amphetamine sulfate, Amphetamine sulphate, Phenaminum, 60-13-9, Amphamine sulfate, Amphetamini sulfas
Molecular Formula
C18H28N2O4S
Molecular Weight
368.5  g/mol
InChI Key
PYHRZPFZZDCOPH-UHFFFAOYSA-N
FDA UNII
6DPV8NK46S

Amphetamine Sulfate
Amphetamine Sulfate is the sulfate salt form of amphetamine, a synthetic substance related to natural sympathomimetic amines. Amphetamine appears to exert its central nervous system (CNS) and peripheral effects indirectly by inducing the release of biogenic amines from their storage sites in nerve terminals. This agent is a commonly abused psychostimulant drug, which may be snorted, taken orally, smoked, or injected. Amphetamine induces psychologic dependence which is manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. With sustained use, the effects of tachycardia and enhanced alertness diminish while psychotoxic effects such as hallucinations and delusions may occur. (NCI04)
1 2D Structure

Amphetamine Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-phenylpropan-2-amine;sulfuric acid
2.1.2 InChI
InChI=1S/2C9H13N.H2O4S/c2*1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2*2-6,8H,7,10H2,1H3;(H2,1,2,3,4)
2.1.3 InChI Key
PYHRZPFZZDCOPH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=CC=C1)N.CC(CC1=CC=CC=C1)N.OS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
6DPV8NK46S
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Dl-amphetamine Sulfate

2. Amphetamine Sulphate

3. Phenaminum

4. 60-13-9

5. Amphamine Sulfate

6. Amphetamini Sulfas

7. Dl-phenamine Sulfate

8. Dl-amphetamine Sulphate

9. Amphetaminium Sulfuricum

10. Desoxynorephedrine Sulfate

11. (+-)-amphetamine Sulfate

12. Dl-amphetamine Hydrogen Sulfate

13. (+-)-phenisopropylamine Sulfate

14. Amfetamine Sulfate

15. Amphetamine Sulfate [usp]

16. Dl-1-phenyl-2-aminopropane Sulfate

17. (+-)-2-amino-1-phenylpropane Sulfate

18. (+-)-alpha-methylphenethylamine Sulfate (2:1)

19. 6dpv8nk46s

20. 1-phenylpropan-2-amine Sulfate (2:1)

21. Amphetamine Sulfate (usp)

22. Fenopromin Sulfate

23. Penamine (van)

24. Ccris 3644

25. 1-phenyl-2-aminopropane Sulfate

26. Cerm 1767

27. Razemisches Phenylaminopropansulfat

28. Dl-alpha-methylphenethylamine Sulfate

29. Einecs 200-457-8

30. Unii-6dpv8nk46s

31. Nsc 170999

32. Dl-amphetamine Sulfate Salt

33. Benzadrine

34. Alpha-methylphenethylamine Sulfate, (+-)-

35. Benzedrine (tn)

36. Evekeo (tn)

37. Evekeo Odt

38. Rac-amphetamine Sulphate

39. D-amphetamine Sulfate Salt

40. Schembl41204

41. Amphetamine Sulfate [mi]

42. Dtxsid4020082

43. Phenethylamine, Alpha-methyl-, Sulfate (2:1), (+-)-

44. Chebi:51063

45. Amfetamine Sulfate [mart.]

46. Amphetamine Sulfate [vandf]

47. Amfetamine Sulfate [who-dd]

48. Bis{1-phenylpropan-2-amine} Sulfate

49. Amfetamine Sulfate [ep Impurity]

50. Amfetamine Sulfate [ep Monograph]

51. Amphetamine Sulfate [orange Book]

52. .beta.-phenylisopyropylaminesulfate

53. Benzeneethanamine, Alpha-methyl-, Sulfate

54. Amphetamine Sulfate [usp Monograph]

55. Amfetamine Sulfate [incb:green List]

56. Delcobese Component Amphetamine Sulfate

57. D02074

58. (+/-)-2-amino-1-phenylpropane Sulfate

59. (+/-)-2-amino-1-phenylpropane Sulphate

60. Amphetamine Sulfate Component Of Delcobese

61. Q21270844

62. (+/-)-.alpha.-methylphenethylamine Sulfate (2:1)

63. (+/-)-.alpha.-methylphenethylamine Sulphate (2:1)

64. Benzeneethanamine, .alpha.-methyl-, Sulfate (2:1), (+/-)-

65. Benzeneethanamine, .alpha.-methyl-, Sulphate (2:1), (+/-)-

66. Dl-amphetamine Sulfate Salt Solution, Drug Standard, 1.0 Mg/ml In Methanol

67. 2-(tetrahydro-furan-2-yl)-n-(3-trifluoromethyl-phenyl)-succinamicacid

68. 156-31-0

2.3.2 Other Synonyms

1. Amfetamine

2. Mydrial

3. Desoxynorephedrine

4. L Amphetamine

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 368.5 g/mol
Molecular Formula C18H28N2O4S
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass368.17697855 g/mol
Monoisotopic Mass368.17697855 g/mol
Topological Polar Surface Area135 Ų
Heavy Atom Count25
Formal Charge0
Complexity166
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3

Listed Suppliers

read-more
read-more

01

Curia

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCuria - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Flag U.S.A
Digital Content Digital Content

Amphetamine

About the Company : Curia is a leading global CDMO with over 30 years of experience supporting clients across drug discovery, development, and commercial manufacturing. Leveraging deep scientific expe...

Curia is a leading global CDMO with over 30 years of experience supporting clients across drug discovery, development, and commercial manufacturing. Leveraging deep scientific expertise, we deliver integrated solutions spanning small molecules, generic APIs, sterile drug products, and biologics. Our robust global network, advanced technologies, and flexible, scalable teams enable efficient development and reliable supply, accelerating the journey of high-quality therapies from concept to patients worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

02

Veranova

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

Amphetamine

About the Company : Veranova is a global leader in developing and manufacturing specialist and complex APIs for pharma and biotech customers, with over 50 years of experience supporting the healthcare...

Veranova is a global leader in developing and manufacturing specialist and complex APIs for pharma and biotech customers, with over 50 years of experience supporting the healthcare industry and building trusted customer relationships. Operating in two divisions-Generics and Originators-it offers tailored services for every stage of the drug development lifecycle. Macfarlan Smith Limited trades as Veranova in the United Kingdom. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Veranova

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMalladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

Flag India
Digital Content Digital Content

Dexamphetamine

About the Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top API manufacturer in th...

Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top API manufacturer in the cough and cold segment, with strong presence in antihistamines, anti-convulsants, anti-depressants, and anxiolytics. Malladi exports to around 60 countries, with over 85% revenue from exports, and its facilities are approved by FDA, EDQM, KFDA, TGA, and other agencies. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Malladi

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Dexamfetamine

About the Company : Supriya Lifescience Limited, established in 1987 and headquartered in Mumbai, is a globally recognized, technology-driven manufacturer of APIs, CDMO, and formulations. Its faciliti...

Supriya Lifescience Limited, established in 1987 and headquartered in Mumbai, is a globally recognized, technology-driven manufacturer of APIs, CDMO, and formulations. Its facilities in Lote and Ambernath are approved by USFDA, EUGMP, Health Canada, and other agencies. Specializing in antihistamines, antiallergics, vitamins, anesthetics, and anti-asthmatics, Supriya serves 1500+ customers in over 86 countries, with 15+ USDMFs, 10+ CEPs, and a 1050 KL manufacturing capacity. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Supriya

05

Siegfried AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSiegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

Flag Switzerland
Digital Content Digital Content

Amphetamine Sulfate

About the Company : Siegfried is a global Contract Development and Manufacturing Organization providing integrated services for pharmaceutical ingredients & finished dosage forms. With 13 production s...

Siegfried is a global Contract Development and Manufacturing Organization providing integrated services for pharmaceutical ingredients & finished dosage forms. With 13 production sites across three continents, we support customers across the full value chain, from process development and optimization to manufacturing, packaging, and logistics. Founded in 1873 in Zofingen, Switzerland, Siegfried combines deep pharmaceutical and chemical expertise with global scale to deliver high-quality medicines reliably to patients worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

06

AXYNTIS Group

France
BIO International Convention
Not Confirmed
arrow

AXYNTIS Group

France
arrow
BIO International Convention
Not Confirmed

Amphetamine Sulfate

About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...

Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of APIs in France through acquisitions & partnerships. It has two divisions (dyes and fine chemicals) and places a strong focus on diversification and innovation. It operates 3 cGMP sites in France, of which 2 are FDA-inspected. It provides CDMO services to its partners for their API or advanced intermediate projects, from early-stage development to the commercial phase, including preparative chromatography (Kyrapharm subsidiary). It also commercializes proprietary APIs.
blank

07

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

d-Amphetamine Sulfate

About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...

Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice. We create value for customers through manufacturing excellence, reliable quality and innovative science. Our people are the experts that our customers enjoy working with.
blank

08

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Amphetasul

About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...

Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the multi-purpose synthetic production facility just south of Copenhagen. Chr. Olesen Synthesis is initially active with API’s comprising of molecules like Hydromorphone, Codeine Phosphate, Pramipexole, Terbinafine Risedronate, Tolfenamic Acid, Amphetamine derivatives and advanced intermediates for Buprenorphine and Tamsulosin.
blank

09

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Amphetamine Sulphate

About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...

At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biotransformation, we develop fully backward-integrated platforms, creating a first-mover advantage in global markets. A leading manufacturer of Schedule-1 and Schedule-2 substances, Embio excels in controlled substances, intermediates, and chiral molecules. Our US-FDA, PMDA, KFDA, COFEPRIS, and WHO-GMP-approved facility in MIDC Mahad serves 70+ countries, including top 10 pharma companies.
blank

10

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Dextroamphetamine

About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Amphetamine Sulfate, a controlled substance targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder (ADHD).


Lead Product(s): Amphetamine Sulfate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 08, 2026

Granules India

01

Lead Product(s) : Amphetamine Sulfate,Inapplicable

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Amphetamine Sulfate, a controlled substance targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder (ADHD).

Product Name : Dyanavel-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

January 08, 2026

Granules India

Details:

Amphetamine Sulfate, a small molecule product targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder.


Lead Product(s): Amphetamine Sulfate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Adzenys XR-ODT-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 22, 2025

Granules India

02

Lead Product(s) : Amphetamine Sulfate,Inapplicable

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Amphetamine Sulfate, a small molecule product targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder.

Product Name : Adzenys XR-ODT-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

December 22, 2025

Granules India

Details:

Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.


Lead Product(s): Amphetamine Sulfate,Amphetamine Aspartate,Dextroamphetamine Saccharate

Therapeutic Area: Psychiatry/Psychology Brand Name: Amphetamine-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 24, 2023

Granules India

03

Lead Product(s) : Amphetamine Sulfate,Amphetamine Aspartate,Dextroamphetamine Saccharate

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extr...

Product Name : Amphetamine-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 24, 2023

Granules India

Details:

FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.


Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate

Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 30, 2021

Granules India

04

Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.

Product Name : Adderall-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

December 30, 2021

Granules India
  • Development Update

Details:

Methylphenidate HCl is a controlled substance drug, which is currently being evaluated in Phase IV clinical studies for the treatment of attention deficit disorder with hyperactivity.


Lead Product(s): Methylphenidate Hydrochloride,Amphetamine Sulfate

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Controlled Substance

Sponsor: Tris Pharma Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 16, 2026

blank

05

Boston Children's Hospital

Country
arrow
BIO International Convention
Not Confirmed

Boston Children's Hospital

Country
arrow
BIO International Convention
Not Confirmed

Details : Methylphenidate HCl is a controlled substance drug, which is currently being evaluated in Phase IV clinical studies for the treatment of attention deficit disorder with hyperactivity.

Product Name : Undisclosed

Product Type : Controlled Substance

Upfront Cash : Inapplicable

June 16, 2026

blank

Details:

Amphetamine Sulfate, a miscellaneous product targeting Norepinephrine transporter and Dopamine transporter, shows promise in treating attention deficit hyperactivity disorder (ADHD).


Lead Product(s): Amphetamine Sulfate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 08, 2026

blank

06

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Amphetamine Sulfate, a miscellaneous product targeting Norepinephrine transporter and Dopamine transporter, shows promise in treating attention deficit hyperactivity disorder (ADHD).

Product Name : Dyanavel

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 08, 2026

blank
  • Development Update

Details:

Amphetamine Sulfate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.


Lead Product(s): Amphetamine Sulfate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Premier Research Group

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 11, 2025

blank

07

Aytu BioPharma, Inc.

Country
arrow
BIO International Convention
Not Confirmed

Aytu BioPharma, Inc.

Country
arrow
BIO International Convention
Not Confirmed

Details : Amphetamine Sulfate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 11, 2025

blank

Details:

Through the acquisition of Amphetamine Sulfate, a controlled substance targeting Norepinephrine transporter and Dopamine transporter, the deal aims to advance neuroscience research.


Lead Product(s): Amphetamine Sulfate,Inapplicable

Therapeutic Area: Psychiatry/Psychology Brand Name: Evekeo-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Aurobindo Pharma Limited

Deal Size: $250.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition July 31, 2025

blank

08

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Through the acquisition of Amphetamine Sulfate, a controlled substance targeting Norepinephrine transporter and Dopamine transporter, the deal aims to advance neuroscience research.

Product Name : Evekeo-Generic

Product Type : Controlled Substance

Upfront Cash : Undisclosed

July 31, 2025

blank

Details:

Adderall-Generic is a CNS stimulant, which is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy.


Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate,Dextroamphetamine Sulphate

Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 17, 2025

blank

09

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Adderall-Generic is a CNS stimulant, which is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy.

Product Name : Adderall-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

April 17, 2025

blank

Details:

Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.


Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate

Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall XR-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 21, 2024

blank

10

Lupin Ltd

India
arrow

Details : Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.

Product Name : Adderall XR-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

November 21, 2024

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMalladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

CAS Number : 25394-33-6

End Use API : Amphetamine Sulfate

About The Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top AP...

Malladi

02

PMC Isochem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

CAS Number : 3182-95-4

End Use API : Amphetamine Sulfate

About The Company : PMC Isochem, acquired by PMC International in 2017, is a CDMO manufacturing cGMP intermediates, APIs, and functional excipients for global pharmaceutical and pe...

PMC Isochem

03

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 103-79-7

End Use API : Amphetamine Sulfate

About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

AMPHETAMINE SULFATE

Brand Name : AMPHETAMINE SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date : 2020-07-14

Application Number : 213898

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

AMPHETAMINE SULFATE

Brand Name : AMPHETAMINE SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Approval Date : 2020-07-14

Application Number : 213898

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date : 1999-05-13

Application Number : 40299

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 5MG

Approval Date : 2019-06-21

Application Number : 205077

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2019-06-21

Application Number : 205077

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 15MG

Approval Date : 2019-06-21

Application Number : 205077

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 5MG

Approval Date : 2017-10-31

Application Number : 205673

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2017-10-31

Application Number : 205673

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

DEXTROAMPHETAMINE SULFATE

Brand Name : DEXTROAMPHETAMINE SULFATE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 15MG

Approval Date : 2017-10-31

Application Number : 205673

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

10

GRANULES

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AA

AMPHETAMINE SULFATE

Brand Name : AMPHETAMINE SULFATE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Approval Date : 2019-08-05

Application Number : 212619

RX/OTC/DISCN : RX

RLD : No

TE Code : AA

Granules India
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 10M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 10MG

USFDA APPLICATION NUMBER - 17078

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 15M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 15MG

USFDA APPLICATION NUMBER - 17078

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 5MG

USFDA APPLICATION NUMBER - 17078

read-more

DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - ...DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML

USFDA APPLICATION NUMBER - 204325

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTEN...DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE

USFDA APPLICATION NUMBER - 204326

read-more

DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - ...DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - 2MG/ML;EQ 0.5MG BASE/ML

USFDA APPLICATION NUMBER - 208147

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12MG...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12MG;EQ 3MG BASE

USFDA APPLICATION NUMBER - 210526

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 16MG...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 16MG;EQ 4MG BASE

USFDA APPLICATION NUMBER - 210526

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 4MG;...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 4MG;EQ 1MG BASE

USFDA APPLICATION NUMBER - 210526

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 8MG;...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 8MG;EQ 2MG BASE

USFDA APPLICATION NUMBER - 210526

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 1.2...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG

USFDA APPLICATION NUMBER - 21303

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 2.5...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG

USFDA APPLICATION NUMBER - 21303

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 3.7...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG

USFDA APPLICATION NUMBER - 21303

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 5MG...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG

USFDA APPLICATION NUMBER - 21303

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 6.2...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG

USFDA APPLICATION NUMBER - 21303

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 7.5...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

USFDA APPLICATION NUMBER - 21303

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Category : Co-Processed Excipients, Fillers, Diluents & Binders

02

EUROAPI

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Grade : Oral

Category : Fillers, Diluents & Binders

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Grade : Oral

Category : Fillers, Diluents & Binders, Taste Masking

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Grade : Oral (Pharma Grade)

Category : Fillers, Diluents & Binders

Brand Name : KoVidone® K25

Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

arrow

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral

Category : Parenteral

Brand Name : Lactose Monohydrate

Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

arrow

08

Pfanstiehl

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

click full view

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

click full view

Direct Compression

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 156-31-0 / Amphetamine Sulfate API manufacturers, exporters & distributors?

Amphetamine Sulfate manufacturers, exporters & distributors 1

36

PharmaCompass offers a list of Amphetamine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier.

API | Excipient name

Amphetamine Sulfate

Synonyms

Dl-amphetamine sulfate, Amphetamine sulphate, Phenaminum, 60-13-9, Amphamine sulfate, Amphetamini sulfas

Cas Number

156-31-0

Unique Ingredient Identifier (UNII)

6DPV8NK46S

About Amphetamine Sulfate

Amphetamine Sulfate is the sulfate salt form of amphetamine, a synthetic substance related to natural sympathomimetic amines. Amphetamine appears to exert its central nervous system (CNS) and peripheral effects indirectly by inducing the release of biogenic amines from their storage sites in nerve terminals. This agent is a commonly abused psychostimulant drug, which may be snorted, taken orally, smoked, or injected. Amphetamine induces psychologic dependence which is manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. With sustained use, the effects of tachycardia and enhanced alertness diminish while psychotoxic effects such as hallucinations and delusions may occur. (NCI04)

Dexamphetamine Manufacturers

A Dexamphetamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexamphetamine, including repackagers and relabelers. The FDA regulates Dexamphetamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexamphetamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Dexamphetamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Dexamphetamine Suppliers

A Dexamphetamine supplier is an individual or a company that provides Dexamphetamine active pharmaceutical ingredient (API) or Dexamphetamine finished formulations upon request. The Dexamphetamine suppliers may include Dexamphetamine API manufacturers, exporters, distributors and traders.

click here to find a list of Dexamphetamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Dexamphetamine USDMF

A Dexamphetamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexamphetamine active pharmaceutical ingredient (API) in detail. Different forms of Dexamphetamine DMFs exist exist since differing nations have different regulations, such as Dexamphetamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Dexamphetamine DMF submitted to regulatory agencies in the US is known as a USDMF. Dexamphetamine USDMF includes data on Dexamphetamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexamphetamine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Dexamphetamine suppliers with USDMF on PharmaCompass.

Dexamphetamine CEP

A Dexamphetamine CEP of the European Pharmacopoeia monograph is often referred to as a Dexamphetamine Certificate of Suitability (COS). The purpose of a Dexamphetamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dexamphetamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dexamphetamine to their clients by showing that a Dexamphetamine CEP has been issued for it. The manufacturer submits a Dexamphetamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dexamphetamine CEP holder for the record. Additionally, the data presented in the Dexamphetamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dexamphetamine DMF.

A Dexamphetamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dexamphetamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Dexamphetamine suppliers with CEP (COS) on PharmaCompass.

Dexamphetamine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexamphetamine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Dexamphetamine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Dexamphetamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Dexamphetamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexamphetamine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Dexamphetamine suppliers with NDC on PharmaCompass.

Dexamphetamine GMP

Dexamphetamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Dexamphetamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dexamphetamine GMP manufacturer or Dexamphetamine GMP API supplier for your needs.

Dexamphetamine CoA

A Dexamphetamine CoA (Certificate of Analysis) is a formal document that attests to Dexamphetamine's compliance with Dexamphetamine specifications and serves as a tool for batch-level quality control.

Dexamphetamine CoA mostly includes findings from lab analyses of a specific batch. For each Dexamphetamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Dexamphetamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexamphetamine EP), Dexamphetamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexamphetamine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty